Danilo De Gregorio
Danilo De Gregorio
Department of Psychiatry, McGill University, Montreal, Qc, Canada
Verified email at mail.mcgill.ca
TitleCited byYear
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice
F Guida, L Luongo, F Marmo, R Romano, M Iannotta, F Napolitano, ...
Molecular brain 8 (1), 47, 2015
622015
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice
F Guida, F Turco, M Iannotta, D De Gregorio, I Palumbo, G Sarnelli, ...
Brain, behavior, and immunity 67, 230-245, 2018
342018
Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety‐like behavior
R Imperatore, G Morello, L Luongo, U Taschler, R Romano, ...
Journal of neurochemistry 135 (4), 799-813, 2015
302015
MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice
E Palazzo, R Romano, L Luongo, S Boccella, D De Gregorio, ...
Pain 156 (6), 1060-1073, 2015
262015
Dorsal striatum metabotropic glutamate receptor 8 affects nocifensive responses and rostral ventromedial medulla cell activity in neuropathic pain conditions
F Rossi, I Marabese, M De Chiaro, S Boccella, L Luongo, F Guida, ...
Journal of neurophysiology 111 (11), 2196-2209, 2013
222013
d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology
D De Gregorio, S Comai, L Posa, G Gobbi
International journal of molecular sciences 17 (11), 1953, 2016
192016
Palmitoylethanolamide reduces neuropsychiatric behaviors by restoring cortical electrophysiological activity in a mouse model of mild traumatic brain injury
F Guida, S Boccella, M Iannotta, D De Gregorio, C Giordano, C Belardo, ...
Frontiers in pharmacology 8, 95, 2017
162017
Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain
L Posa, D De Gregorio, G Gobbi, S Comai
Current medicinal chemistry 25 (32), 3866-3882, 2018
152018
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
D De Gregorio, L Posa, R Ochoa-Sanchez, R McLaughlin, S Maione, ...
Pharmacological research 113, 81-91, 2016
152016
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice
S Maione, L Radanova, D De Gregorio, L Luongo, L De Petrocellis, ...
European journal of pharmacology 748, 115-122, 2015
122015
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ...
Pain 160 (1), 136, 2019
102019
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
A Aguilar-Valles, N Haji, D De Gregorio, E Matta-Camacho, ...
Nature Communications 9 (1), 2459, 2018
62018
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
DG De, JP Enns, NA Nu˝ez, L Posa, G Gobbi
Progress in brain research 242, 69-96, 2018
42018
Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain
S Boccella, F Guida, F De Logu, D De Gregorio, M Mazzitelli, C Belardo, ...
The FASEB Journal 33 (1), 1062-1073, 2018
32018
Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications and perspectives
S Comai, M Lopez-Canul, D De Gregorio, A Posner, M Ettaoussi, ...
Pharmacological research, 2019
12019
Role of palmitoylethanolamide (PEA) in depression: Translational evidence
D De Gregorio, M Manchia, B Carpiniello, F Valtorta, M Nobile, G Gobbi, ...
Journal of affective disorders, 2018
12018
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain
F MŘller, ME Liechti, UE Lang, S Borgwardt, MR Wilson, A Webb, LJ Wylie, ...
Progress in brain research 242, 159-177, 2018
12018
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle
M Lˇpez-Canul, SH Min, L Posa, D De Gregorio, A Bedini, G Spadoni, ...
International journal of molecular sciences 20 (10), 2452, 2019
2019
hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders
D De Gregorio, JP Enns, NA Nunez, L Posa, G Gobbi
Psychedelic Neuroscience 242, 69, 2018
2018
D-lysergic diethylamide modulates dopaminergic neurons of ventral tegmental area via 5-HT1A, D2 and TAAR1 receptors
D De Gregorio, L Posa, R Ochoa-Sanchez, R McLaughlin, S Maione, ...
European Neuropsychopharmacology, S53-S54, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20